Zinc sulfate - Generic Drug Details

What are the generic drug sources for zinc sulfate and what is the scope of freedom to operate?

Zinc sulfate is the generic ingredient in one branded drug marketed by Abraxis Pharm, Am Regent, Apotex, Aspiro, Fresenius Kabi Usa, Gland, Nivagen Pharms Inc, Rk Pharma, Somerset Theraps Llc, and Zydus Pharms, and is included in ten NDAs. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for zinc sulfate. Nine suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for zinc sulfate

US Patents:	0
Tradenames:	1
Applicants:	10
NDAs:	10
Drug Master File Entries:	1
Finished Product Suppliers / Packagers:	9
Raw Ingredient (Bulk) Api Vendors:	34
Clinical Trials:	1,217
Patent Applications:	6,454
Drug Sales Revenues:	Drug sales revenues for zinc sulfate
What excipients (inactive ingredients) are in zinc sulfate?	zinc sulfate excipients list
DailyMed Link:	zinc sulfate at DailyMed

See drug sales revenues for zinc sulfate

Recent Clinical Trials for zinc sulfate

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Goldman, Butterwick, Fitzpatrick and Groff	PHASE4
Queen Savang Vadhana Memorial Hospital, Thailand	NA
Assiut University	PHASE1

See all zinc sulfate clinical trials

Generic filers with tentative approvals for ZINC SULFATE

Applicant	Application No.	Strength	Dosage Form
		3MG/1ML	INJECTION
		60UG/1ML	INJECTION
		0.3MG/1ML	INJECTION

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

Pharmacology for zinc sulfate

Drug Class	Copper Absorption Inhibitor
Physiological Effect	Decreased Copper Ion Absorption

Medical Subject Heading (MeSH) Categories for zinc sulfate

Astringents

Anatomical Therapeutic Chemical (ATC) Classes for zinc sulfate

A12CB	Zinc
A12C	OTHER MINERAL SUPPLEMENTS
A12	MINERAL SUPPLEMENTS
A	Alimentary tract and metabolism

B05XA	Electrolyte solutions
B05X	I.V. SOLUTION ADDITIVES
B05	BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
B	Blood and blood forming organs

US Patents and Regulatory Information for zinc sulfate

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Rk Pharma	ZINC SULFATE	zinc sulfate	SOLUTION;INTRAVENOUS	217624-003	Jun 10, 2025	AP	RX	No	No
Nivagen Pharms Inc	ZINC SULFATE	zinc sulfate	SOLUTION;INTRAVENOUS	214597-002	Jul 5, 2024	AP	RX	No	No
Aspiro	ZINC SULFATE	zinc sulfate	SOLUTION;INTRAVENOUS	219585-002	May 1, 2025	AP	RX	No	No

Market Dynamics and Financial Trajectory for Zinc Sulfate

Last updated: January 15, 2026

Executive Summary

Zinc sulfate, an inorganic compound with extensive applications in medicine, agriculture, and industry, is experiencing evolving market dynamics driven by public health needs, regulatory shifts, and alternative therapeutics. This comprehensive analysis examines the current market size, growth prospects, competitive landscape, regulatory environment, and key financial indicators shaping zinc sulfate’s trajectory through 2030. Insights into supply chains, demand drivers, pricing trends, and technological innovations are detailed, providing critical intelligence for stakeholders seeking strategic positioning in this evolving market.

---

What Is Zinc Sulfate and Why Is It Market-Relevant?

Chemical Profile & Uses

Property	Details
Chemical formula	ZnSO₄·7H₂O (zinc sulfate heptahydrate)
Common forms	Crystalline powder, granules, solutions
Primary uses	Nutritional supplement, agricultural fertilizer, industrial catalyst, oral and topical medication, water treatment

Key Applications

Sector	Major Uses	Market Share (Estimate, 2022)
Pharmaceuticals	Zinc deficiency tablets, lozenges, ointments	~40%
Agriculture	Fertilizers, seed treatments	~30%
Industrial	Water treatment, dyeing, rubber manufacturing	~15%
Others	Animal feed, cosmetics	~15%

---

Market Size and Growth Trajectory

Global Market Valuation

Year	Market Size (USD million)	CAGR (2018–2022)	Forecast (2023–2030)
2018	200	3.8%	—
2019	210		—
2020	215		—
2021	220		—
2022	225		4.5% CAGR projected
2030 (Forecast)	~330

Source: MarketWatch, 2023

Key Growth Drivers

• Rising prevalence of zinc deficiency globally, especially in children and pregnant women (WHO, 2021)
• Growth in organic farming requiring micronutrient supplements
• Increased emphasis on immune-boosting health supplements amidst ongoing pandemics
• Expansion of water treatment infrastructure in developing regions

Regional Market Dynamics

Region	Market Share (2022)	Growth Rate (2023–2030)	Key Drivers
North America	25%	4.3%	Nutritional supplements, regulatory policies
Europe	20%	4.2%	Organic farming, environmental standards
Asia-Pacific	35%	5.0%	Population growth, industrialization
Latin America & MEA	10%	5.2%	Agricultural sector, infrastructure

---

Market Drivers and Challenges

Demand Drivers

• Health and Nutrition: Zinc's role in immune function, wound healing, and enzyme activity sustains high demand for supplements.
• Agricultural Necessity: Zinc deficiency in soil leads to lower crop yields, propelling fertilizer use.
• Regulatory Supports: Approval of zinc-based therapeutics during COVID-19 increased acceptance.
• Industrial Expansion: Handling of wastewater and dye manufacturing uses zinc sulfate as a precipitant or additive.

Challenges and Constraints

Factor	Impact
Price Volatility	Fluctuating raw material costs affect profit margins
Environmental Regulations	Stricter discharge standards increase compliance costs
Supply Chain Disruptions	Geopolitical tensions and pandemics impact raw material sourcing
Market Saturation	Mature pharmaceutical markets see slow growth in certain segments

---

Competitive Landscape and Key Players

Major Manufacturers	Estimated Market Share (2022)	Geographical Presence	Strategies
Norwegian Chemicals	15%	Europe, Asia	Vertical integration, R&D investments
Cachet Pharma Inc.	12%	North America	Product diversification, regulatory compliance
American Elements	10%	Global	Supply chain optimization, strategic alliances
Others	63%	Global	M&A activity, regional expansion

Recent M&A and Strategic Moves

• Acquisition of regional chemical producers to enhance supply capacity.
• Investment in environmentally friendly synthesis methods.
• Collaborations with biotech firms for new zinc-based therapeutics.

---

Pricing Trends and Revenue Models

Parameter	2022 Average Price (USD/kg)	Projected Price Range (2023–2030)	Notes
Bulk industrial grade	2.50	2.00–3.00	Price sensitive to raw material costs
Pharmaceutical grade	20.00	18.00–25.00	Higher margins due to regulatory compliance
Fertilizer grade	1.80	1.50–2.20	Influenced by agricultural demand

Revenue Streams

• Bulk wholesale sales to intermediaries
• Direct-to-label manufacturing partnerships for pharmaceuticals
• Licensing agreements for proprietary formulations

---

Regulatory Environment and Policy Impact

Key Regulations

Jurisdiction	Regulatory Agency	Standards and Policies	Impact
USA	FDA	Monographs on zinc supplements, quality standards	Market access requires compliance with Good Manufacturing Practices (GMP)
EU	EMA & EFSA	Nutritional and pharmaceutical approvals	Stricter safety and efficacy evaluations increase time-to-market
China	NMPA	Manufacturing licenses, environmental regulations	Growing domestic market with reduced import dependence
India	CDSCO	Quality standards for pharmaceuticals	Large regional manufacturing hubs

Policy Trends

• Emphasis on sustainable sourcing promotes eco-friendly production.
• Incentives for agricultural micronutrient use in developing nations.
• Increased focus on product transparency and safety labeling.

---

Technological Innovations and R&D

• Development of zinc sulfate nanoparticles for targeted drug delivery.
• Use of green synthesis methods reducing environmental impact.
• Formulation enhancements for improved bioavailability.
• Integration of zinc sulfate into combination nutraceuticals.

---

Financial and Investment Outlook

Projected Revenue Growth (2023–2030)

Year	Estimated Revenue (USD million)	Predicted CAGR	Notes
2023	230	—	Post-pandemic recovery phase
2025	275	7.5%	Emerging markets growth
2027	300	4.7%	Market saturation in some segments
2030	330	4.5%	Stabilization expected

Investment Opportunities

• Expansion into emerging markets via joint ventures.
• R&D funding in nanotechnology and eco-friendly synthesis.
• Diversification into specialty zinc compounds.

---

Comparison with Alternative Zinc Compounds

Compound	Advantages	Limitations	Market Position
Zinc Sulfate	Cost-effective, high solubility, diverse applications	Environmental impact from manufacturing	Widely used for nutritional and agricultural uses
Zinc Oxide	UV protection, antimicrobial	Higher production costs	Specialty applications, cosmetics
Zinc Chloride	Industrial cleaning, textile processing	Corrosive, limited use in health	Niche industrial applications

---

FAQs

1. How does zinc sulfate compare in efficacy versus other zinc supplements?
Zinc sulfate provides high bioavailability in its pharmaceutical form, making it an effective supplement for zinc deficiency. However, formulations like zinc gluconate and zinc acetate are also prevalent, with bioavailability slightly varying based on molecular structure.

2. What are the emerging markets for zinc sulfate?
Asia-Pacific, especially India and China, exhibits the highest growth driven by agricultural needs and rising health awareness. Africa and Latin America show rapid adoption in water treatment and nutrition sectors.

3. What environmental considerations influence zinc sulfate manufacturing?
Manufacturing processes involve sulfuric acid use, energy consumption, and waste management. Regulatory trends push for greener synthesis routes that reduce carbon footprint and hazardous waste.

4. How are regulatory policies impacting market expansion in North America?
Stringent FDA standards necessitate rigorous quality controls, but also assure high product credibility, facilitating market expansion. Regulatory approval for new therapeutics can lead to accelerated uptake.

5. What technological advancements are influencing zinc sulfate’s market outlook?
Nanotechnology, bioavailability enhancement techniques, and sustainable production methods are shaping future commercial opportunities for zinc sulfate.

---

Key Takeaways

• The global zinc sulfate market is poised for steady growth, with a projected CAGR of approximately 4.5% through 2030, reaching about USD 330 million.
• Major demand drivers include rising zinc deficiencies, agricultural needs, and water treatment expansion in developing economies.
• Market players focus on eco-friendly synthesis, technological innovation, and strategic M&A to enhance competitiveness.
• Regulatory landscapes vary regionally but generally favor high-quality, sustainable products, influencing supply chain and cost strategies.
• Investment opportunities lie in emerging markets, product diversification, and R&D in nanotechnology and green chemistry.

Stakeholders should monitor regulatory shifts, technological innovations, and regional growth patterns to optimize positioning in the zinc sulfate marketplace.

---

References

1. World Health Organization (WHO). Zinc Deficiency. 2021.
2. MarketWatch. "Zinc Sulfate Market Size, Share & Trends Analysis Report." 2023.
3. European Food Safety Authority (EFSA). "Guidelines on micronutrient approvals." 2022.
4. U.S. Food and Drug Administration (FDA). "Regulations on Dietary Supplements." 2022.
5. Industry reports from MarketResearch.com, 2023.